Eurofins Scientific
Search results
4 days ago · Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Ipsen is a mid-sized global biopharmaceutical company, improving patients’ lives through research and innovation in oncology, rare disease and neuroscience.
Learn about Ipsen, a global pharma company that aims to prolong patients’ lives, improve health outcomes and create a positive impact for patients and society.
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines ...
5 days ago · PARIS, FRANCE, 25 July 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the first half of 2024. Business ...
5 days ago · PARIS, FRANCE, 25 July 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the first half of 2024. Business highlights. U.S. regulatory approvals and launches of Onivyde ® (irinotecan) in first-line pancreatic cancer and Iqirvo ® (elafibranor) in second-line primary biliary cholangitis, respectively
Ipsen | 230,237 followers on LinkedIn. We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease ...
Feb 13, 2024 · The first-line nod should also contribute to Ipsen’s recently announced goal to grow sales by at least 7% annually between 2023 and 2027 at constant exchange rates.
Cherry Valley, ILLINOIS (January 16, 2023) – Ipsen USA looks forward to celebrating its 75 th anniversary this year, having just completed a record-breaking 2022. Ipsen’s Service, Parts and New Equipment departments each reached historically high sales levels, contributing to record revenue.
Although purchased by Ipsen in the 90s, VFS (Vacuum Furnace Systems) Corporation in Souderton, Pennsylvania, adopts the Ipsen name in 2007. Today, the manufacturing facility is the world’s largest producer of vacuum furnace hot zones.
